Tirzepatide (Mounjaro) KwikPen 5 mg

Tirzepatide (Mounjaro) KwikPen 5 mg

Mounjaro KwikPen 5 mg contains tirzepatide, a prescription medicine administered by subcutaneous injection. Tirzepatide is a dual GIP and GLP-1 receptor agonist used alongside diet and exercise to help improve blood sugar control in adults with type 2 diabetes.

The 5 mg strength is generally used after an initial 2.5 mg starting dose, with further dose adjustments determined by a healthcare professional based on the patient's response and treatment needs.

Important: Prescription medicine. Use only as directed by a qualified healthcare professional. Follow the official instructions for dosing, storage, and administration. Possible side effects include nausea, diarrhea, vomiting, decreased appetite, and other gastrointestinal symptoms. Consult a healthcare professional before use.